1. Rescriptor Product Monograph, Pharmacia & Upjohn.
2. et al. Twice daily dosing of delavirdine (DLV) in combination with nelfinavir (NFV), didanosine (ddI), and stavudine (d4T) results in significant decreases in viral burden. In 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, 1999, San Francisco, CA. American Society for Microbiology: Washington, DC, 1981; Abstract.
3. et al. Salvage therapy with saquinavir sgc (SQV) in combination with ritonavir (RTV) or nelfinavir (NFV) and delavirdine (DLV), adefovir dipivoxil (ADV), or both: ACTG 359. Antivir Ther 1999; 4 (Supp 1): 19.
4. Clinical experience with adding delavirdine to combination therapy in patients in whom multiple antiretroviral treatment including protease inhibitors has failed
5. Viramune Product Monograph, Version 3.0, Boehringer Ingelheim International GmbH.